{"entity":{"id":"derrick-haslem","kind":"person","name":"Derrick S. Haslem","aka":[],"tldr":"Medical oncologist who leads the oncology clinical programme across Intermountain Health's cancer centres in Utah and neighbouring states.","summary":"Derrick S. Haslem is Senior Medical Director of the Oncology Clinical Program at Intermountain Health, the not-for-profit health system whose cancer centres span Utah and surrounding states. He is a board-certified medical oncologist with expertise in targeted therapy, genomics and breast cancer, and completed his haematology and oncology fellowship at Huntsman Cancer Hospital, University of Utah, in 2009. He practises at Intermountain cancer centres in St George, Murray and Logan and has expanded rural access to cancer care through tele-oncology services in Utah, Idaho and Wyoming.","asOf":"2026-09-10","links":[{"label":"Source: Intermountain Health provider profile","url":"https://doctors.intermountainhealth.org/provider/derrick-s-haslem/2556921"}],"tags":["leadership","clinician-scientist","medical-oncology","tele-oncology"],"related":[],"cancers":["breast-hr-positive","breast-her2-positive","tnbc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["intermountain-cancer"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["oncotarget"],"dependsOn":[],"notes":[],"role":"Senior Medical Director of the Oncology Clinical Program, Intermountain Health","institutionId":"intermountain-cancer","specialisms":["Medical oncology","Breast cancer","Cancer genomics and targeted therapy","Tele-oncology"],"profiles":[{"label":"Institution profile","url":"https://doctors.intermountainhealth.org/provider/derrick-s-haslem/2556921"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Haslem+DS%5BAuthor%5D"}],"papers":[{"title":"Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study","journal":"Journal of Clinical Oncology","year":2021,"doi":"10.1200/jco.20.02923"},{"title":"Precision oncology in advanced cancer patients improves overall survival with lower weekly healthcare costs","journal":"Oncotarget","year":2018,"doi":"10.18632/oncotarget.24384"},{"title":"A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs","journal":"Journal of Oncology Practice","year":2017,"doi":"10.1200/jop.2016.011486"}],"orcid":"0009-0000-4469-2086"},"route":"/people/derrick-haslem/","neighbours":{"cancer":[{"id":"breast-her2-positive","kind":"cancer","name":"HER2-positive breast cancer","route":"/cancers/breast-her2-positive/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"tnbc","kind":"cancer","name":"Triple-negative breast cancer (TNBC)","route":"/cancers/tnbc/"}],"institution":[{"id":"intermountain-cancer","kind":"institution","name":"Intermountain Health Cancer Center","route":"/institutions/intermountain-cancer/"}],"journal":[{"id":"oncotarget","kind":"journal","name":"Oncotarget","route":"/journals/oncotarget/"}]}}